For us to put this into a binary categorization is just wrong
The clinical data from ESSENCE showed that at week 72, 36.8% of people treated with Wegovy achieved improvement in liver fibrosis with no worsening of steatohepatitis compared to 22.4% treated with placebo
Always consult with your healthcare provider before starting any new treatment protocol.* Pamela Davis, MD, is in private practice in Los Angeles
Some people also worry about losing muscle mass while they lose fat
At 12 months after discontinuation, Noom members showed roughly threefold lower modeled regain of lost weight than published post-discontinuation benchmarks
Wegovy is FDA approved for chronic weight management in adults with obesity and overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol